DNA Testing for Illegal Ivory Trade

The Convention on International Trade in Endangered Species of Wild Fauna and Flora, or CITES, has increased trade regulations for endangered species like sharks, and it has also acknowledged the role that DNA testing could play in tracing illegal ivory to its source, Nature reports. The conference of the parties, or COP, said that such testing should be required when large seizures are made. Phys.org notes that poaching of the African elephant is at its highest level since the ivory trade was banned in 1989. The CITES resolution says that any country that seizes 500 kilograms (about 1100 pounds) or more of ivory must take samples and test them within 90 days, Phys.org adds.

"I was ecstatic because it was the first time that the entire COP acknowledged the value and need for DNA testing for the origin of poached ivory. All my hard work had finally paid off," Samuel Wasser from the University of Washington and who directs the Center for Conservation Biology tells Nature.

In the Public Square

About 100 organizations are planning a 'Rally for Medical Research' for the beginning of April to protest sequestration cuts' effects on biomedical research.

Jon Retzlaff, the managing director for science policy at the American Association for Cancer Research, one of the organizations involved, tells Nature Medicine's Spoonful of Medicine blog that the rally aims to remind the US Congress that funding the National Institutes of Health should be a priority. The sequester, which went into effect at the beginning of this month, will lead to about a 5 percent, or $1.6 billion, cut to the NIH budget. The rally coincides with AACR's annual meeting in DC.

"Making the NIH a national priority will require the members of [Congress] to step up and say this is an area like we had 10-15 years ago with John Porter [former congressman and chair of the Labor, Health and Human Services subcommittee] in the House and Senators Arlen Specter and Tom Harkin, who together doubled NIH's budget over a five year period and said that the NIH needs to be one of the nation's priorities," Retzlaff tells the Spoonful of Medicine blog.

Retzlaff adds that he expects at least 10,000 people to show up.

This Week in Science

In Science this week, investigators from Nagoya University report data suggesting that it was modification, rather than loss, that resulted in modern day insects lacking wings on certain body regions. Insects today have wings exclusively on the second and third thoracic segments, yet insect fossil records show wing-like pads on other segments. Using RNA interference to silence genes responsible for specific body segment identities, the researchers found that the mealworm beetle was capable of growing wing-like structures on the first thoracic region. The findings indicate that insects did not lose their ability to grow wings in other areas of their bodies, but that modification "provided an additional diversifying mechanism of insect body plan," the researchers write.

Also in Science, a multi-institute team led by Harvard University researchers show that the accumulation of multiple mutations associated with a single gene, as opposed to a single mutation with widespread effects, are responsible for the coat colors of deer mice. When studying a gene known to influence hair color, the scientists found that a variety of genetic variants associated with light coloration were under selection, suggesting that local adaptation results from "independent selection on many mutations within a single locus, each with a specific effect on an adaptive phenotype, thereby minimizing pleiotropic consequences."

Meanwhile, in Science Translational Medicine, a group of scientists and healthcare experts write that while molecular diagnostics are expected to improve healthcare by enabling providers to optimize treatment selection, regulatory and reimbursement challenges threaten to hinder their development and integration into the healthcare system. They propose a variety of changes to existing statutory and regulatory policies and strategies that may help overcome these hurdles.

Your Wait Time Is ...

It takes nearly two years to get results from a clinical trial published, report researchers led by Yale University School of Medicine's Joseph Ross in JAMA Internal Medicine. Ross and his colleagues examined the 1,336 clinical trial publication that came out in 2009 and traced them back using ClinicalTrials.gov, Medline, and National Library of Medicine data to their completion date. From this, they found that the median time to publication was 21 months. A previous study involving members of this group found that between nearly a third and a half of clinical trials are never published.

"Because these studies are taking nearly two years to become available, it is slowing the uptake of the information and slowing progress in research and clinical practice," Ross tells Ed Silverman at Pharmalot.

Growth Ahead

Yang Wei is taking over the National Natural Science Foundation of China, which experienced a large budget increase during his predecessor's tenure, and Yang tells ScienceInsider that the agency expects to see further growth. "Although increases will be less dramatic than in the past 9 years, we still anticipate growth rates higher than China's GDP growth rate [forecast to be 7.5 percent in 2013]," Yang says. Still, he notes that the NSFC budget is 40 percent the size of the US National Science Foundation budget and that one division of the agency competes with the US National Institutes of Health.

At the same time, Yang says he is working to promote research integrity and to improve agency operations. He tells ScienceInsider that an independent research integrity committee has identified five areas of misconduct — credential inflation, plagiarism, assigning favorable reviewers to certain applications, leakage of review information, and submitting false progress reports — that the agency is keeping watch on.

Personal Genetics Plusses

Knowing their genetic information could help people improve their lives and, possibly, avoid preventable deaths, writes 23andMe co-founder Anne Wojcicki in the Guardian's Comment Is Free section. While she acknowledges that it will take years for researchers to uncover what all the billions of bases in the human genome do, she says that enough is currently known to help some people. For example, Wojcicki notes that about 8 percent of people of European descent have a variant that increases their risk for developing blood clots and that there are a number of strategies such people can take to reduce that danger.

She goes on to applaud UK Prime Minister David Cameron's initiative to sequence 100,000 people and create a national database. "This database alone will trigger tremendous understanding of the genome and fuel medical innovation," Wojcicki writes, adding that "the genetic revolution is here."

This Week in Nature

In Nature this week, an international team of researchers present an analysis of tapeworm genome sequences that has uncovered a variety of potential targets for fighting the parasites. Using three human-infective tapeworm species and one lab model, the scientists uncovered gene losses and gains related to the animal’s adaptation to the host environment, such as ones involved in nutrient metabolism, which relates to their ability to absorb nutrients from their hosts. The work revealed new areas for therapeutic intervention, including ones for which existing drugs may be effective.

Our sister publication GenomeWeb Daily News has more on this study here.

Meantime, in Nature Biotechnology, researchers from Harvard University report on a new method to produce siRNAs in Escherichia coli, rather than through chemical synthesis. The technique involves the expression of p19, an siRNA-binding protein found in plant RNA viruses, in E. coli, which stabilizes an 21 nucleotide-long siRNA species produces by the bacterial RNase III. When mammalian cells are transfected with them, siRNAs that were generated in bacteria expressing p19 and a hairpin RNA encoding 200 or more nucleotides of a target gene reproducibly knock down target gene expression by around 90 percent without immunogenicity or off-target effects.

When Jammers and Blockers Collide

Roller derby players block and crash into each other on the track, trying to score points against the other team, and, in doing so, they also affect each other's skin microbiome, researchers from the University of Oregon say.

The researchers, as they report in PeerJ this week, swabbed the upper arms of roller derby players from three teams before and after play. Samples were also obtained from the facility hosting the tournament. The 16S rRNA genes from the samples were then extracted, amplified, and sequenced. While the bacterial taxa found in the samples were consistent with known skin microbiome communities, there were differences noted among the groups.

Each team, the researchers report, had significantly different microbiomes prior to each bout, but after play those differences lessened. Before the Emerald City Roller Girls played Silicon Valley Roller Girls, they shared about 28.2 percent of their skin microbiome OTUs, while, after they played, they shared 32.7 percent of their OTUs. Similarly, the Emerald City Roller Girls and the DC Roller Girls shared 27.3 percent of their OTUs before playing each other and 29.9 percent afterward.

"This study highlights that our interactions with people around us do appear to change our microbiome," Oregon's James Meadow, the first author on the study, tells ScienceNow. "When you ride to work on the subway and bump arms with someone, is that small contact enough to share something?"

On another note, Daily Scan's (randomly generated) roller derby name is Devil Assassin.

A Tale of Disputed Research Results Ends Badly

The sad and sobering tale of how allegedly fabricated results of research led by a Johns Hopkins University lab led to the suicide of a scientist in Taiwan,and the dismissal of the man who blew the whistle, are the focus of a feature in yesterday's Washington Post.

The story is the tale of Daniel Yuan, formerly a genetics researcher in Jeff Boeke's lab at Hopkins. For years, Yuan suggested that data being generated in the lab's studies of gene interactions in yeast were suspicious.

Yuan was dismissed from Hopkins in 2011, and last summer one of the members of the research team, Yu-yi Lin, was found dead in his new lab in Taiwan of an apparent suicide.

Lin was an author of a paper published in Nature last year that now, according to the Washington Post, may soon be corrected by the journal. At age 38, Lin left behind a wife and three daughters.

The article suggests that Yuan was fired because of his concerns that the data that was used to write the Nature paper and others did not support the conclusions reported. Yuan also reached out to the editors at Nature, warning the journal of the weakness of the data behind the paper, saying that its results were overstated and that some of the analyses outlined in the paper may not have been conducted at all.

After Lin was found dead, Yuan received an e-mail "essentially blaming him for driving Lin to suicide," the Post reports.

The Post feature also suggests that the saga of Yuan and Lin are part of a larger trend of falsified research and unfounded research conclusions being published because of the immense pressure caused by an increasing number of scientists who are racing to win grants in an environment of diminishing funding.

An 'Omics Orchestra

An orchestra with a sick tuba player and a lead violinist who is missing her bow — this is how Reinhard Hiller, co-director of South Africa's Center for Proteomic and Genomic Research sees the state of genomics and proteomics in Africa today. Writing on CPGR's blog, Hiller describes a situation on the continent where investments made in human resources are not sustained as top scientists often emigrate for better employment opportunities, infrastructure is mismanaged and isolated, and countries compete against each other rather than developing a regional strategy for success. "The net effect is that investments into physical and human resources don't yield proper returns in terms of scientific publications, patents, and biomedical innovation," Hiller writes.

According to Hiller, the solution to these challenges is network orchestration, the "art of assembling an array of resources into seamless strings of value generation." He says that African genomics and proteomics infrastructure should be reassembled in an "agile, customer-focused fashion" based on principles of "network, cooperation, and coordination." With alternative resources built into the resulting network, Hiller says that African genomics and proteomics infrastructure would also be "resilient to external and internal turbulence." In addition, Hiller says that Africa is particularly poised to benefit from network orchestration. "Where else, if applied properly, can these principles have more positive impact than in a resource-scarce environment, such as in many of the emerging economies in Africa?" he writes.

The HeLa Difference

HeLa cells are ubiquitous in biomedical research — indeed, there have even been reports of HeLa cells contaminating and taking over other cell lines in the lab. By sequencing and transcriptomic analyses, researchers from the European Molecular Biology Laboratory and University Hospital Heidelberg report in G3: Genes, Genomes and Genetics that a number of pathways in HeLa cells "exhibit significantly different expression patterns from those in normal human tissues."

The researchers, led by EMBL's Lars Steinmetz, performed DNA and RNA sequencing of a HeLa Kyoto cell line and examined its mutational profile and gene expression levels, finding about 4.5 million SNVs and half a million indels. The cell line also exhibits an extensive amount of chromosomal rearrangements to the point of chromothripsis, the researchers add. In addition, about 2,000 genes are expressed at a higher level in the HeLa cell line than in normal tissue, and those genes appear to mainly be involved in proliferation, transcription, and DNA repair. "The high expression of some DNA repair genes, some of which also carry potentially damaging NS mutations, suggests that even though HeLa displays high chromosomal instability, specific DNA repair mechanisms may be activated, perhaps irrespective of their effectiveness," the researchers write.

"Our study underscores the importance of accounting for the abnormal characteristics of HeLa cells in experimental design and analysis, and has the potential to refine the use of HeLa cells as a model of human biology," Steinmetz adds in a statement.

NSF's New Acting Director

ScienceInsider reports that the US National Science Foundation has tapped Cora Marrett, a sociologist and academic administrator, to serve as its acting director after current head Subra Suresh steps down on March 22 until a permanent replacement is appointed and confirmed.

Suresh is vacating the role after holding it for two and half years to become the president of Carnegie Mellon University.

Marrett is the deputy director of the NSF, a post she's occupied since 2009. This isn't the first time that she has managed the institution while its leadership changed hands, according to the article. She was in charge in between the departure of former head Arden Bement in May 2010 and Suresh taking over in October of the same year. She's also run education programs and headed up the NSF's social and behavioral sciences directorate.

ScienceInsider adds that some former directors say Marrett should take over the role on a permanent basis, though it notes that only one deputy has become director throughout the agency's history.

This Week in Genome Biology

Researchers from the US and France used comparative genomics to begin defining the core and accessory genomes of nitrogen-fixing root nodule bacteria from a genus called Sinorhizobium. The team started by sequencing and assembling draft genomes for four dozen strains representing five so-called genospecies: S. meliloti, S. medicae, S. fredii, S. saheli, and S. terangae. From there, they compared sequences across the strains, particularly with respect to each strain's capabilities and preferred host plants. "The diversity of genes present in the accessory genomes of members of [the Sinorhizobium] genus indicates that each bacterium has adopted slightly different strategies to interact with diverse plant genera and soil environments," the University of Minnesota's Michael Sadowsky and colleagues say.

A study led by the University of Bristol's Seirian Sumner looks at transcriptional profiles contributing to primitive forms of eusocial insect behavior. Together with colleagues from the UK, Spain, and Switzerland, Sumner (who was based at the Zoological Society of London while the research was carried out) performed transcriptome sequencing on brain tissue from tropical paper wasps representing different social castes. The group's results indicate that the brain transcriptomes of worker wasps tend to be more active those of queen wasps, showing particularly pronounced expression differences at uncharacterized genes. For more on the study, check out GenomeWeb Daily News.

A team from Germany and the US describes work done delineating a de novo assembly of the newt transcriptome. The researchers turned to Sanger, Illumina, and Roche 454 sequencing techniques to assemble RNA sequences representing nearly 121,000 non-redundant transcripts for the red spotted newt, Notophthalmus viridescens, an amphibian with large, complicated, and yet-unsequenced genome. Among the newly assembled sequences were more than 800 transcripts that appear to be specific to the urodeles — an order that includes newts, salamanders, and other amphibians that regenerate limbs or tissues — suggesting some of these transcripts may contribute to the regeneration process. "Our data provide the groundwork for mechanistic experiments to answer the question [of] whether urodeles utilize proprietary sets of genes for tissue regeneration," they write.

GWDN has more on that study, here.